UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

Form 6-K

 

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of November, 2016

Commission File Number                         

 

 

Novogen Limited

(Translation of registrant’s name into English)

 

 

Level 5, 20 George Street, Hornsby, NSW 2077, Australia

(Address of principal executive office)

 

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F   þ              Form 40-F   ¨

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):   ¨

Note : Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders.

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):   ¨

Note : Regulation S-T Rule 101(b)(7) only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized (the registrant’s “home country”), or under the rules of the home country exchange on which the registrant’s securities are traded, as long as the report or other document is not a press release, is not required to be and has not been distributed to the registrant’s security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other Commission filing on EDGAR.

Indicate by check mark if the registrant by furnishing the information contained in this form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934. Yes   ¨      No   þ

If “yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b)

 

 

 


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Novogen Limited (Registrant)

Kate Hill

Kate Hill

Interim Company Secretary

Date 16 November 2016


LOGO

16 November 2016

Manager Companies

Company Announcements Office

Australian Securities Exchange

Level 4, Stock Exchange Centre

20 Bridge Street

SYDNEY NSW 2000

Dear Sir

RESULTS OF ANNUAL GENERAL MEETING

NOVOGEN LIMITED

In accordance with Listing Rule 3.13.2 and section 251AA of the Corporations Act, we advise details of the resolutions and proxies received in respect of each resolution, as set out in the attached summary.

Yours faithfully

 

LOGO

Kate Hill

Company Secretary

 

LOGO


Novogen Limited

Annual General Meeting

Wednesday, 16 November 2016

Voting Results

The following information is provided in accordance with section 251AA(2) of the Corporations Act 2001 (Cth).

 

Resolution details

   Instructions given to validly appointed proxies
(as at proxy close)
   Number of votes cast on the poll
(where applicable)
   Resolution
Result

Resolution

   Resolution
Type
   For    Against    Proxy’s
Discretion
   Abstain    For    Against    Abstain*    Carried /
Not Carried

1 Remuneration Report

   Ordinary    22,287,586    27,574,670    160,065,579    1,933,159    194,845,577    38,269,971    1,933,159    Carried
      10.62%    13.14%    76.24%       83.58%    16.42%      

2 Re-election of Mr Steven R. Coffey as a Director

   Ordinary    60,053,111    27,490,307    160,115,579    1,223,419    236,574,953    34,440,440    1,238,419    Carried
      24.25%    11.10%    64.65%       87.29%    12.71%      

3 Re-election of Mr John P. O’Connor as a Director

   Ordinary    65,716,920    21,223,798    160,135,579    1,806,119    242,478,301    27,969,392    1,806,119    Carried
      26.60%    8.59%    64.81%       89.66%    10.34%      

4 Renewal of approval of additional capacity to issue 10% of securities

   Special    55,403,224    32,458,502    160,126,080    894,610    232,009,273    39,349,929    894,610    Carried
      22.34%    13.09%    64.57%       85.50%    14.50%      

5 Adoption of New Constitution

   Special    79,816,855    6,565,135    160,118,179    2,382,247    257,779,003    12,077,562    2,397,247    Carried
      32.39%    2.66%    64.95%       95.52%    4.48%      

* Votes cast by a person who abstains on an item are not counted in calculating the required majority on a poll.

Kazia Therapeutics (NASDAQ:KZIA)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Kazia Therapeutics Charts.
Kazia Therapeutics (NASDAQ:KZIA)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Kazia Therapeutics Charts.